CHECKMATE GOVERNMENT RELATIONS

Lobbying for GSK · Pharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · $50,000.00 income · posted Oct 19, 2025

Lobbying activity 2

Health Issues

No current bills filed. Focused engagement with HHS regarding pharmaceutical technology.

Pharmacy

No current bills filed. Focused engagement with HHS regarding pharmaceutical technology.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.